Kevin Joseph Harrington

60PUBLICATIONS
528CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMolecular targetsPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Nov 10, 2026
Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma: CSCO and ASCO Joint Guideline.

|Nov 10, 2026
Treatment of Stage IB to III Nasopharyngeal Carcinoma: CSCO-ASCO Guideline Update.

|Oct 15, 2026
Preclinical efficacy of a systemically-administered, second-generation STING agonist that promotes anti-tumour immunity in combination with radiotherapy.

|Oct 12, 2026
Addition of chemotherapy to radiotherapy promotes progenitor-exhausted CD8⁺ T-cell clonal dominance in head and neck cancer.

|Oct 01, 2026
Setanaxib Added to Pembrolizumab for Fibroblast-Rich, Recurrent, or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Phase II Randomized Study.

|Sep 15, 2026
Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.

Pageof 10

Frequent Collaborators

17 joint publications

Alan Melcher

13 joint publications

Emmanuel Patin

10 joint publications

Pablo Nenclares

10 joint publications

Charleen Ml Chan Wah Hak